CAPILLARY CAPILLARY NSE
Company Profile ↓Company Overview
CAPILLARY (CAPILLARY) is a publicly traded company listed on NSE with a market capitalization of ₹3,987.83 Cr. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 33.9% CAGR over the past five years.
Carries low leverage with a debt-to-equity ratio of 0.05.
Recent Developments
- Mar 2026 Revenue of ₹734.60 Cr (+22.8% YoY); net profit ₹52.39 Cr.
- Trailing 12 Months Year-on-year growth — revenue +22.8%, earnings +294.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 33.9%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 33.85% |
| 1 Year: | 22.79% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | 294.49% |
Stock Price Performance
| 1 Year: | -17.20% |
| 6 Months: | -20.32% |
| 3 Months: | -9.92% |
| 1 Month: | -0.38% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- RSI (14)43.74 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 33.9% over 5 years.
CONS
- Trading at a high P/E of 299.9.
- Trading 31.4% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Dec 2024 | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 159.00 Cr | 152.08 Cr | 179.00 Cr | 184.03 Cr | 191.35 Cr |
| Cost of Revenue | 98.94 Cr | 89.21 Cr | - | 122.58 Cr | 122.27 Cr |
| Gross Profit | 60.06 Cr | 62.87 Cr | - | 61.45 Cr | 69.08 Cr |
| Operating Expenses | 49.94 Cr | 51.83 Cr | 161.00 Cr | 55.56 Cr | 57.20 Cr |
| Operating Income | 10.12 Cr | 11.04 Cr | 0 | 5.89 Cr | 11.88 Cr |
| EBITDA | 24.46 Cr | 30.04 Cr | 19.00 Cr | 28.66 Cr | 63.06 Cr |
| Interest Expense | 1.67 Cr | 1.60 Cr | 2.00 Cr | 1.46 Cr | 1.07 Cr |
| Pretax Income | 9.94 Cr | 11.95 Cr | -0 | 8.12 Cr | 42.48 Cr |
| Tax Provision | -1.47 Cr | -1.07 Cr | 0 | 12.80 L | -88.90 L |
| Net Income | 10.26 Cr | 9.84 Cr | 0 | 7.99 Cr | 43.36 Cr |
| Diluted EPS | 1.29 | 1.24 | 0.04 | 1.04 | 5.40 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | 171.00 Cr | 223.00 Cr | 255.37 Cr | 525.10 Cr | 598.26 Cr | 734.60 Cr |
| Cost of Revenue | - | - | 204.48 Cr | 384.21 Cr | 387.70 Cr | 483.08 Cr |
| Gross Profit | - | - | 50.89 Cr | 140.89 Cr | 210.55 Cr | 251.52 Cr |
| Operating Expenses | 184.00 Cr | 274.00 Cr | 152.98 Cr | 203.26 Cr | 205.69 Cr | 233.64 Cr |
| Operating Income | -31.00 Cr | -80.00 Cr | -102.09 Cr | -62.37 Cr | 4.86 Cr | 17.88 Cr |
| EBITDA | -13.00 Cr | -51.00 Cr | -45.02 Cr | -20.00 L | 80.67 Cr | 131.54 Cr |
| Interest Expense | 2.00 Cr | 9.00 Cr | 10.30 Cr | 16.84 Cr | 7.79 Cr | 5.46 Cr |
| Pretax Income | -23.00 Cr | -103.00 Cr | -94.89 Cr | -75.26 Cr | 10.68 Cr | 51.11 Cr |
| Tax Provision | -23.00 L | 2.06 Cr | -6.33 Cr | -6.91 Cr | -3.47 Cr | -1.28 Cr |
| Net Income | -23.00 Cr | -101.00 Cr | -87.72 Cr | -59.38 Cr | 13.28 Cr | 52.39 Cr |
| Diluted EPS | -97.84 | -20.16 | -11.06 | -7.49 | 1.67 | - |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Total Assets | 140.00 Cr | 347.00 Cr | 466.41 Cr | 871.07 Cr | 838.65 Cr | 1,300.24 Cr |
| Current Assets | - | - | 149.83 Cr | 465.17 Cr | 418.22 Cr | 720.99 Cr |
| Cash & Equivalents | - | - | 46.20 Cr | 180.67 Cr | 201.25 Cr | 35.81 Cr |
| Inventory | - | - | - | - | - | - |
| Receivables | - | - | 80.11 Cr | 145.65 Cr | 161.12 Cr | 180.84 Cr |
| Total Liabilities | - | - | 279.84 Cr | 332.12 Cr | 270.41 Cr | 276.75 Cr |
| Current Liabilities | - | - | 224.06 Cr | 309.18 Cr | 250.70 Cr | 257.42 Cr |
| Long Term Debt | - | - | 43.21 Cr | 4.17 Cr | 1.28 Cr | 0 |
| Total Debt | 20.00 Cr | 83.00 Cr | 149.47 Cr | 80.31 Cr | 106.43 Cr | 53.61 Cr |
| Total Equity | 12.00 Cr | 116.00 Cr | 186.57 Cr | 538.95 Cr | 568.25 Cr | 1,023.49 Cr |
| Shares Outstanding | - | - | 7.93 Cr | 7.93 Cr | 7.93 Cr | 7.94 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.00 Cr | 7.00 Cr | -20.06 Cr | 97.14 Cr | -46.20 Cr | 149.91 Cr |
| Investing Cash Flow | -14.00 Cr | -113.00 Cr | -93.62 Cr | -184.53 Cr | 63.58 Cr | -613.95 Cr |
| Financing Cash Flow | 28.00 Cr | 96.00 Cr | 136.57 Cr | 217.76 Cr | 3.69 Cr | 270.50 Cr |
| Capital Expenditure | -12.00 Cr | -17.00 Cr | -28.20 Cr | -36.93 Cr | -47.46 Cr | -362.61 Cr |
| Free Cash Flow | -11.00 Cr | -10.00 Cr | -48.26 Cr | 60.20 Cr | -93.66 Cr | -212.71 Cr |
| Net Change in Cash | 15.00 Cr | -9.00 Cr | 22.89 Cr | 130.37 Cr | 21.07 Cr | -193.54 Cr |
Ratios (Annual)
Figures in %.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Gross Margin % | - | - | 19.9% | 26.8% | 35.2% | 34.2% |
| Operating Margin % | -18.1% | -35.9% | -40.0% | -11.9% | 0.8% | 2.4% |
| Net Margin % | -13.5% | -45.3% | -34.3% | -11.3% | 2.2% | 7.1% |
| ROE % | -191.7% | -87.1% | -47.0% | -11.0% | 2.3% | 5.1% |
| ROCE % | - | - | -42.1% | -11.1% | 0.8% | 1.7% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CAPILLARY
CAPILLARY Stock Price and Chart — NSE:CAPILLARY - TradingView
<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1KX05SYmVkLVFZbklOQ2kzT2tQR0ZocHp0VF9MT2dtN24wN2E1UGZ2bDBEOW1LN3ZLSEZkSHhoaldDOXA5NXo0WVZEM0JHbU9hblNWVmdXdVNSUGIxLVgw?oc=5" target="_blank">CAPILLARY Stock Price and Chart — NSE:C…
Impressive Earnings May Not Tell The Whole Story For Capillary Technologies India (NSE:CAPILLARY) - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi7AFBVV95cUxNWDdDVW90eTB2WldsRmx2bEpxVzdremxDU0VYTGcteHpkUXZOM3JBa3hvZkNlb1FDZHlWN1QyaVptMnB0V0dOSzBPXzlIa1BuZjZuam5vaVd1Y0c3OEJFUXlnQXNhSmRGVGROLWFxdGg2WkRxQWdtajFoLU9UenM3SUw1MWJOazFHZHhOc2…
Capillary Technologies India Limited to host virtual investor meet on July 15 - scanx.trade
<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxOaDZXdjlPdGlYejBmWUR1ZVAzR0wyeXlhd0NiTkx5Z3VhemZHSGdyTUFtMUpWa203dnBtQmlrd1hiRXVyUExSSGdiUHU2ZG1PVUpDVnZodFdjSWJtM1BkVjRJRl96c2tGOG1YSjMyZ1FOVU9xODZYZDJFQjNRSHFHY0tvUkt3aUl0bmp2X1…
Capillary Tech Emerges Biggest Loser Among New-Age Tech Stocks Amid IT Selloff - Inc42
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxPQTJlMm92ejMtOTY5MFBHMmE2ZW5aWU5vZTlyYXhIdEJDNnR1VVBsM0lDWnYwcGIteTRUY0MzZi1OX2JnalRWUDU3TldNV2VSVm9Sb3dOemZjWEpvS3UwR2xQXy1KbTB3bHJzYVpKSWVKVG1qU0dheHV5d2FGSUJRaTJHZ0JfSXpjcE5ZcT…
Capillary Technologies shares rocket up to 13% after tepid debut. Should you buy, sell or hold the stock? - The Economic Times
<a href="https://news.google.com/rss/articles/CBMihgJBVV95cUxNbzVNd0IweVk5akF1UzZYaWtCdENzdUNrcDA4RnN4WWczallPOWUxWHRVWGNpT1Y0YWJoZDVBVE90YWVneGdmLWw0ZURhZUV5Vlh5TjAxUEFaSUxsZHNoOHNKN2c0anZXN01aa3h2N1FSc1gzWXJHVXRyMmQyNWxBenUwcUg4Y1ozOGUtbU…
Capillary Technology posts Rs 184 Cr revenue in Q3 FY26; profit falls 20% - Entrackr
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxONHZacXRNajhDa2NKaWJuVm41NjlMSW5nV00zOWxvejlOSVhMZFJ2azZkbFR0dmk0YVRCa3lSS1YtX1pxbU5ybEVpejB6eWFld1JhN2VnRXZzbmdGdTUweFJibDNDWEktSDlwd2t2NU9pNGQza0FrVXladXdFM0RuODBUdWFNeTdOdTFvWk…
CAPILLARY — Frequently Asked Questions
What is the current share price of CAPILLARY?
As of 2026-07-15 09:52 IST, CAPILLARY trades at ₹502.20 on NSE. Its 52-week range is ₹471.00 to ₹732.15.
What is the market capitalisation of CAPILLARY?
CAPILLARY has a market capitalisation of ₹3,987.83 Cr on NSE.
What is the P/E ratio of CAPILLARY?
CAPILLARY trades at a trailing price-to-earnings (P/E) ratio of 299.93. Its price-to-book (P/B) ratio is 3.91.
What is the return on equity (ROE) of CAPILLARY?
CAPILLARY has a return on equity (ROE) of 5.12%. Its return on capital employed (ROCE) is 1.71%.
Is CAPILLARY a good stock to buy?
This page provides a data-driven analysis of CAPILLARY, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.